1.
Gisondi P, Chiricozzi A, Pani M, Povero M, Castello L, Pedone MP, et al. [Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]. FE [Internet]. 2025 May 8 [cited 2025 Jul. 22];26(1). Available from: https://provafe.seedstm.com/index.php/FE/article/view/1571